Inhibition of central nervous system effects from smoking and sensory effects from smoking
Abstract:
Pharmaceutical compositions and methods of use therefor for reducing the desire to engage in smoking are disclosed. More specifically, the pharmaceutical composition utilizes an active ingredient to reduce the side effects of smoking cessation and to limit the molecular feedback caused by nicotine-mediated activation of acetylcholine receptors.
Information query
Patent Agency Ranking
0/0